Concepedia

Paul B. Chapman

PB

179

Publications

42.4K

Citations

73

H-Index

1978

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Massachusetts General Hospital

University of California, Los Angeles

Peter MacCallum Cancer Centre

Paul B. Chapman is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1978–2023

179

Publications

179

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Paul B. Chapman, Axel Hauschild, Caroline Robert et al. · New England Journal of Medicine · 2011 · 7.6K citations · Full text

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

Héctor Peinado, Maša Alečković, Simon Lavotshkin et al. · Nature Medicine · 2012 · 3.6K citations · Full text

, , +12

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Keith T. Flaherty, Igor Puzanov, Kevin B. Kim et al. · New England Journal of Medicine · 2010 · 3.5K citations · Full text

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Axel Hauschild, Jean‐Jacques Grob, Lev Demidov et al. · The Lancet · 2012 · 2.9K citations

, , +6

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

Gideon Bollag, Peter Hirth, James Tsai et al. · Nature · 2010 · 1.8K citations

, , +7

Rows per page

1–5 of 179